
Apmonia Therapeutics
Developer of peptide-based biotechnology designed to provide therapeutic strategies for multiple types of cancer. The company focuses on creating drugs to treat glioblastoma, ovarian, colorectal, and ...
Valuation
$26.8M
Latest known
Share Price
N/A
Total Raised
$12.1M
Last Round
N/A